ATI develops innovative medical devices for the ophthalmological market, dramatically improving the patient's experience during diagnostic procedures while increasing clinical efficiency. Our flagship product, FIM, achieves full pupil dilation in 90–120 seconds — drug-free.
A diagnostic procedure that hasn't changed in decades — reimagined for the modern clinic.
ATI develops innovative medical devices for the ophthalmological market, which dramatically improve the patient's experience during diagnostic procedures while increasing their efficiency. Founded in 2005 by a group of seasoned entrepreneurs in ophthalmology and electromechanical devices, ATI today employs an experienced multidisciplinary team with many groundbreaking innovations.
ATI's flagship product, FIM (Field Induced Mydriasis), is the world's first pupil dilation device — achieving full dilation within 90–120 seconds and full recovery within minutes, safely, non-contact and drug-free.
Unlike dilation eye drops, FIM achieves full pupil dilation in 90–120 seconds, with recovery to normal condition in under 120 seconds — using safe electromagnetic fields instead of medication.
Unlike eye drops, FIM is completely drug-free and requires no contact with the patient's eyes.
Upon switching off the device, the pupil recovers to normal condition within minutes, without side effects.
The patient does not experience any pain or discomfort during or after the procedure.
FIM is seamlessly installed on any standard slit lamp by manually installing the Ocular Front-end unit into the existing slot.
FIM is seamlessly integrated with standard slit lamp examination procedures — no added steps.
FIM uses safe electromagnetic fields that conform to the CE standard.
FIM has completed large-scale clinical research at Tel Aviv Sourasky Medical Center, been introduced at the Israel Eye Microsurgery Conference, and is now moving into its second generation — with a new personal ocular tonometer, NIT, in development for early glaucoma detection.
Read our news